Merck & Co., Inc. 

(Public, NYSE:MRK)   Watch this stock   
Find more results for MRK
Feb 16, 2010
Q4 2009 Earnings Conference Call - 8:00AM EST - Add to calendar
Feb 15, 2010
Q4 2009 Earnings Release Add to calendar
Jan 12, 2010
JPMorgan Healthcare Conference - Webcast
Jan 6, 2010
Goldman Sachs CEO Unplugged Conference - Webcast
Nov 12, 2009
Credit Suisse Healthcare Conference - Webcast
More events from AOL Finance »    

Key stats and ratios

Q3 (Sep '09) 2008
Net profit margin 57.12% 32.74%
Operating margin 83.92% 41.12%
EBITD margin - 36.77%
Return on average assets 28.24% 16.34%
Return on average equity 63.32% 42.27%
Employees 55,200 -

Address

One Merck Drive P.O. Box 100
Whitehouse Station, NJ 08889
United States - Map
+1-908-4231000 (Phone)
+1-908-7351253 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com
About Company - Wikipedia

Merck & Co., Inc. discussions

  View all discussions »

Description

Merck & Co., Inc. (Merck) is a global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of products to improve human and animal health. The Company’s operations are principally managed on a products basis and consist of two business segments. The Pharmaceutical segment includes human health pharmaceutical products marketed either directly or through joint ventures. These products consist of therapeutic and preventive agents, sold by prescription, for the treatment of human disorders. The Vaccines and Infectious Diseases segment includes human health vaccine products marketed either directly or through a joint venture. These products consist of preventative pediatric, adolescent and adult vaccines, primarily administered at physician offices. Infectious disease products consist of therapeutic agents for the treatment of infection sold primarily to drug wholesalers and retailers, hospitals and government agencies.

Officers and directors

Richard T. Clark
Chairman of the Board, President, Chief Executive Officer
Age: 62
Bio & Compensation - Reuters
Peter N. Kellogg
Chief Financial Officer, Executive Vice President
Age: 53
Bio & Compensation - Reuters
Adam H. Schechter
President - Global Pharmaceuticals
Age: 44
Bio & Compensation - Reuters
Stefan Oschmann
President, Europe, Middle East, Africa & Canada
Age: 51
Bio & Compensation - Reuters
Julie Gerberding
President - Merck Vaccines
Bio & Compensation - Reuters
J. Chris Scalet
Executive Vice President - Global Services, Chief Information Officer
Age: 50
Bio & Compensation - Reuters
Bruce N. Kuhlik
Executive Vice President, General Counsel
Age: 52
Bio & Compensation - Reuters
Mirian M. Graddick-Weir
Executive Vice President - Human Resources
Age: 54
Bio & Compensation - Reuters
Kenneth C. Frazier
Executive Vice President and President - Global Human Health
Age: 54
Bio & Compensation - Reuters
Peter S. Kim Ph.D.
Executive Vice President and President - Merck Research Laboratories
Age: 50
Bio & Compensation - Reuters